The Brain Reset Breakthrough — The NeuroNovaCo Story | Ep 32 | Fountain of Vitality

Researchers spent seven years failing to find a non-drug way to produce dopamine in the brain. Then one scientist, on a hunch, tried 80 Hz vibration on lab rats and found 200% of baseline dopamine in a single session. That accident became a NIH-funded clinical trial, a 60% reduction in generalized anxiety, and eventually a chair you can sit in at home. Thomas Wilkinson lost his brother to a methadone overdose. Now he's the CEO bringing that technology to families across America.

0:00
0:00
Advertising will end in
play_arrow
pause
replay_10
forward_10
volume_up
volume_down
volume_off
share
speed
Skip ad
close
close
close
close
close

Description:

Researchers spent seven years failing to find a non-drug way to produce dopamine in the brain. Then one scientist, on a hunch, tried 80 Hz vibration on lab rats and found 200% of baseline dopamine in a single session. That accident became a NIH-funded clinical trial, a 60% reduction in generalized anxiety, and eventually a chair you can sit in at home. Thomas Wilkinson lost his brother to a methadone overdose. Now he's the CEO bringing that technology to families across America.

In this episode of Fountain of Vitality, host LaMont Leavitt sits down with Thomas Wilkinson, CEO of NeuroNova, to explore how targeted spinal vibration at 80 Hz triggers a physiological release of dopamine without drugs or invasive procedures. Thomas shares the research origins at Brigham Young University, his personal battle with anxiety and chemical dependency on four prescribed medications, and what a world-renowned sleep researcher discovered when he checked Thomas's Oura Ring data at a conference in Arizona.

If anxiety, insomnia, or stress has you searching for something beyond medication, this conversation will change how you think about what's possible. Listen now on Fountain of Vitality and share it with someone who needs to hear it.

Follow the Fountain of Vitality podcast: Website - FountainofVitality.com | Tiktok - @FountainofVitalitypod | YouTube - @FountainofVitalityshow | Tumblr - @FountainofVitality | Facebook - FountainofVitalityShow | Rumble - Fountain_of_Vitality | Instagram - @FountainofVitalitypodcast | Email - contact@FountainofVitality.com

Follow LaMont Leavitt: LinkedIn - @LaMontJLeavitt/ | Twitter/X - @ljleavitt1 |
InnoviHealth Website - innoviHealth.com

Follow Thomas Wilkinson, CEO of NeuroNova: LinkedIn - @Thomas-Wilkinson-7b74316a | Website - NeuroNovaCo.com | Instagram - @NeuroNovaCo | TikTok/X- @NeuroNovaCo | LinkedIn - @NeuroNovaCo

GUEST INFO:

Thomas Wilkinson, CEO of NeuroNova

Thomas Wilkinson is the CEO of NeuroNovaCo, a company commercializing 80 Hz vibration technology originally developed at Brigham Young University to help the brain produce dopamine naturally. After losing his brother in a substance use recovery center and battling his own chemical dependency on anxiety medications, Thomas purchased the technology and partnered with the lead neuroscientist to bring it to market. NeuroNovaCo is currently in a multi-state FDA trial funded by a $3.5 million NIH grant.

Related Podcast

Journey from AI Emotion to Responsible AI Governance | Ep 30 | Fountain of Vitality

What happens when AI can read emotion and stay safe for the enterprise today? In this episode of the Fountain of Vitality podcast, host LaMont Leavitt sits down with Craig Tucker, CEO and founder of VERN AI, to trace a 10 year journey that began with a goal, to build a companion for his grandmother who was alone.

Listen Now
Crisis as a Catalyst for Growth - The Nivati Journey | Ep 17 | Fountain of Vitality

What happens when your thriving six-million-dollar business drops to zero revenue in ten days? Amelia Wilcox, founder and CEO of Nivati, reveals how Friday the 13th marked the beginning of corporate massage's collapse as COVID sent every office worker home indefinitely.

Listen Now
What is the Future of Levemir Insulin? | Ep 12 | Fountain of Vitality

What happens when the insulin that keeps your daughter alive suddenly disappears from the market? Alison Smart, President of Insulin Choice, reveals the shocking removal of Levamir insulin affecting over one million Americans, particularly athletes, pregnant women, and teenagers whose survival depends on this specific formulation. In this episode of Fountain of Vitality with host LaMont Leavitt, featuring Alison Smart, explore why Novo Nordick discontinued a proven insulin for weight loss drug profits, the dangerous myth that all insulin are interchangeable, and the three pathways to saving this life-sustaining medication. Alison discusses how her 13-year-old daughter's type 1 diabetes diagnosis launched a national advocacy campaign, why pregnant women face increased complications without proven insulin options, the manufacturer ready to produce Levamir with proper support, and FDA petition deadlines that could determine whether millions lose access to their only effective diabetes treatment. Learn the critical differences between basal insulin formulations, pregnancy safety concerns with alternative options, and specific actions listeners can take to prevent a healthcare crisis affecting families nationwide.

Listen Now
Aspirational Healthcare: Next Generation of Customer-Centric Healthcare | Ep 24 | Fountain of Vitality

What happens when 70,000 Alaska Native people with some of the worst population health outcomes in the world build a healthcare system from scratch—asking customers what they want instead of doctors dictating treatment?

Listen Now
View All

Subscribe Our Channel On Many Platform

Comments